Next Article in Journal
Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial
Next Article in Special Issue
RETRACTED: Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans
Previous Article in Journal
Solid Form and Phase Transformation Properties of Fexofenadine Hydrochloride during Wet Granulation Process
 
 
Review

Article Versions Notes

Pharmaceutics 2021, 13(6), 803; https://doi.org/10.3390/pharmaceutics13060803
Action Date Notes Link
article pdf uploaded. 27 May 2021 16:14 CEST Version of Record https://www.mdpi.com/1999-4923/13/6/803/pdf-vor
article xml file uploaded 28 May 2021 11:46 CEST Original file -
article xml uploaded. 28 May 2021 11:46 CEST Update https://www.mdpi.com/1999-4923/13/6/803/xml
article pdf uploaded. 28 May 2021 11:46 CEST Updated version of record https://www.mdpi.com/1999-4923/13/6/803/pdf
article html file updated 28 May 2021 11:47 CEST Original file -
article html file updated 28 May 2021 11:48 CEST Update -
article html file updated 26 July 2022 21:40 CEST Update https://www.mdpi.com/1999-4923/13/6/803/html
Back to TopTop